SD Biosensor, Inc (KRX: 137310)

Market Cap	1.23T
Revenue (ttm)	674.07B
Net Income (ttm)	-63.22B
Shares Out	122.35M
EPS (ttm)	-516.98
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	440,373
Open	9,560
Previous Close	9,590
Day's Range	9,470 - 10,050
52-Week Range	7,870 - 15,340
Beta	0.99
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About SD Biosensor

SD Biosensor, Inc, an in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally. The company’s products include STANDARD Q, which provides various rapid test parameters comprising COVID-19 products and other parameters; STANDARD F, a multi-parametric and random accessible FIA system that provides diagnostic results to the laboratories; and STANDARD E, an enzyme linked immunosorbent assay for mass screening tests. Its products also include STANDARD M, a point-of-care MDx system for clinical decis...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2010
• Employees: 576
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 137310